NOVO NORDISK CFO: IF CATALENT DEAL DOES NOT CLOSE, MORE CAPEX WILL BE NEEDED TO BUILD FILL-FINISH CAPACITY INTERNALLY
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
873.1 DKK | -2.74% | -2.04% | +25.07% |
May. 02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
May. 02 | Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.07% | 556B | |
+29.68% | 681B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.68% | 235B | |
+4.71% | 199B | |
-12.43% | 189B | |
-3.79% | 157B | |
-3.34% | 149B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk Cfo: If Catalent Deal Does Not Close, More Capex W…